Clipping of news on Brazilian Culture, Law and Citizenship
03/11/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Time of drug use influences the likelihood of developing this type of cancer
According to a study, the greater the usage time of the remedy, the lower the risk of developing the disease
CALIFORNIA - A new study finds that women who take aspirin have a reduced risk of developing melanoma - and the longer the duration of use, the lower the risk. The results suggest that aspirin has anti-inflammatory drugs that can help protect against skin cancer such. The research was originally published in the journal "Cancer", the American Cancer Society.
When experts from the School of Medicine, Stanford University analyzed data from women aged between 50 and 79 years, for 12 years, they found that those who took aspirin more were less likely to develop skin cancer like melanoma. Overall, women who took the drug had a 21 percent lower risk of having the disease than nonusers.
Each increase in usage time (less than a year old, four years old, and five or more years of use) was associated with a 11 percent lower risk of melanin. Thus, women who used aspirin for five or more years had a 30 percent less risk than women who did not. The researchers controlled for differences in pigmentation, tanning practices, use of sunscreen, and other factors that may affect the risk of this type of skin cancer.
Doctors now use the study to support the design of a clinical trial to directly test whether aspirin can be taken to prevent melanoma.
Read more on this in # http://oglobo.globo.com/saude/aspirina-pode-reduzir-risco-de-melanoma-7788115 ixzz2NEz7Da00
Source: The Globe - Online
Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.